Torstein Baade Rø
Torstein Baade Rø
Vice-dean research, professor
Department of Clinical and Molecular Medicine Faculty of Medicine and Health SciencesBackground and activities
Vice dean of research
Education: MD 1996 (NTNU). PhD 2006 (NTNU). Specialist in paediatrics 2008.
Teaching subjects: General pediatrics. Pediatric endocrinology. Adolescent medicine.
Research: I am interested in basic research on growth of B-cell cancers (multiple myeloma, lymphoma, leukemia), and I am presently focusing on the phosphatase PRL-3's role in B-cell cancers. I am also involved in clinical research on diabetes mellitus, more specifically impaired awareness of hypoglycemia in children and adolescents with diabetes.
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
2022
- (2022) Assessment of Executive Function in Everyday Life—Psychometric Properties of the Norwegian Adaptation of the Children’s Cooking Task. Frontiers in Human Neuroscience. vol. 15.
- (2022) Validity of the Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C) in children and adolescents with pediatric acquired brain injury. Neuropsychological Rehabilitation.
- (2022) Predictors of Functional School Outcome in Children With Pediatric Acquired Brain Injury. Frontiers in Neurology.
2021
- (2021) Phosphatase of Regenerating Liver-3 Regulates Cancer Cell Metabolism in Multiple Myeloma. The FASEB Journal.
- (2021) Rehabilitation of executive function in chronic paediatric brain injury: a randomized controlled trial. BMC Medicine. vol. 19 (1).
- (2021) Targeting phosphoglycerate dehydrogenase in multiple myeloma. Experimental hematology and oncology.
- (2021) Fatigue Following Pediatric Acquired Brain Injury: Interplay With Associated Factors in a Clinical Trial Population Compared to Healthy Controls. Neuropsychology. vol. 35 (6).
- (2021) Factors related to educational adaptations and social life at school experienced by young people with CFS/ME: a qualitative study. BMJ Open. vol. 11 (11).
- (2021) Experiences among school personnel and school nurses on educational adaptations for students with CFS/ME: A qualitative interview study. Frontiers in pediatrics.
- (2021) PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2. The FEBS Journal. vol. 288 (23).
2020
- (2020) Health-related quality of life in Norwegian adolescent living with chronic fatigue syndrome. Health and Quality of Life Outcomes.
- (2020) Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Journal for ImmunoTherapy of Cancer (JITC).
2019
- (2019) Considering formulation characteristics when prescribing and dispensing medicinal products for children: a qualitative study among GPs and pharmacists. Family Practice. vol. 36 (3).
- (2019) Assessing awareness of hypoglycemia in children and adolescents with type 1 diabetes: Evaluation of established questionnaires. Pediatric Diabetes.
- (2019) Paediatric goal management training in patients with acquired brain injury: study protocol for a randomised controlled trial. BMJ Open. vol. 9:e029273 (8).
2018
- (2018) Register-based study showed that the age when children were prescribed antibiotic tablets and capsules instead of liquids increased from 2004 to 2016. Acta Paediatrica.
- (2018) Requests for new oral antibiotic prescriptions in children within 2 days: a Norwegian population-based study. Family Practice. vol. 35 (6).
- (2018) Fear of hypoglycaemia and its relation to hypoglycaemia awareness and symptom intensity in Type 1 diabetes. Diabetes Research and Clinical Practice. vol. 137.
- (2018) Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. Experimental hematology and oncology. vol. 7:8.
- (2018) Effect of High Intensity Interval Training on Cardiac Function in Children with Obesity: A Randomised Controlled Trial. Progress in cardiovascular diseases. vol. 61 (2).